Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bartee

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Nature Reviews. Immunology|August 22, 2009
Cytokine determinants of viral tropismGrant McFadden, Mohamed R Mohamed, Masmudur M Rahman, et al.
Molecular Therapy. Oncology|September 18, 2024
IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockadeMiriam Valenzuela-Cardenas, Carrie Fisher, Mee Y Bartee, et al.
Plos One|August 21, 2012
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cellsEric Bartee, Amy Meacham, Elizabeth Wise, et al.
Molecular Therapy Oncolytics|September 21, 2023
Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infectionRaquela J Thomas, Mee Y Bartee, Miriam Valenzuela-Cardenas, et al.
Advances in Virology|February 8, 2012
Oncolytic virotherapy for hematological malignanciesSwarna Bais, Eric Bartee, Masmudur M Rahman, et al.
Journal of Virology|January 15, 2004
Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteinsEric Bartee, Mandana Mansouri, Bianca T Hovey Nerenberg, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapyMiriam Valenzuela-Cardenas, Cody Gowan, Parker Dryja, et al.
Molecular Therapy. Oncology|October 27, 2025
Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levelsParker Dryja, Erica B Flores, Mee Y Bartee, et al.
Immunometabolism (Cobham, Surrey)|January 16, 2025
Navigating a complex dance: the interplay between RNA-binding proteins and T cells in oral epithelial plasticityAnitha Vijayakumar, Sekar Vasudevan, Samu John, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2012
Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virusEric Bartee, Winnie M Chan, Jan S Moreb, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Nature Reviews. Immunology|August 22, 2009
Cytokine determinants of viral tropismGrant McFadden, Mohamed R Mohamed, Masmudur M Rahman, et al.
Molecular Therapy. Oncology|September 18, 2024
IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockadeMiriam Valenzuela-Cardenas, Carrie Fisher, Mee Y Bartee, et al.
Plos One|August 21, 2012
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cellsEric Bartee, Amy Meacham, Elizabeth Wise, et al.
Molecular Therapy Oncolytics|September 21, 2023
Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infectionRaquela J Thomas, Mee Y Bartee, Miriam Valenzuela-Cardenas, et al.
Advances in Virology|February 8, 2012
Oncolytic virotherapy for hematological malignanciesSwarna Bais, Eric Bartee, Masmudur M Rahman, et al.
Journal of Virology|January 15, 2004
Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteinsEric Bartee, Mandana Mansouri, Bianca T Hovey Nerenberg, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapyMiriam Valenzuela-Cardenas, Cody Gowan, Parker Dryja, et al.
Molecular Therapy. Oncology|October 27, 2025
Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levelsParker Dryja, Erica B Flores, Mee Y Bartee, et al.
Immunometabolism (Cobham, Surrey)|January 16, 2025
Navigating a complex dance: the interplay between RNA-binding proteins and T cells in oral epithelial plasticityAnitha Vijayakumar, Sekar Vasudevan, Samu John, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2012
Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virusEric Bartee, Winnie M Chan, Jan S Moreb, et al.
Pageof 5